MarketPulse

clinical trial misconduct

4 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Llp

Soleno Therapeutics Faces Class Action Over Alleged Safety Misrepresentations

Robbins LLP files class action against $SLNO over safety concerns regarding its Prader-Willi syndrome drug, following critical exposé and patient death disclosure.
SLNOclass action lawsuitstock decline
GlobeNewswire Inc.GlobeNewswire Inc.··Glancy Prongay Wolke & Rotter Llp

Soleno Therapeutics Faces Securities Fraud Lawsuit Over DCCR Safety Disclosures

Class action lawsuit filed against $SLNO over alleged securities fraud tied to DCCR safety concerns, patient death, and disappointing Q3 results that triggered sharp stock declines.
SLNOsecurities fraudclass action lawsuit
BenzingaBenzinga··Glancy Prongay Wolke & Rotter Llp

Soleno Therapeutics Faces Securities Fraud Lawsuit Over DCCR Safety Claims

Class action lawsuit filed against $SLNO over alleged securities fraud tied to DCCR drug safety concerns, patient death, and disappointing Q3 results.
SLNOsecurities fraudclass action lawsuit
BenzingaBenzinga··Law Offices Of Howard G. Smith

Soleno Therapeutics Faces Securities Fraud Suit Over DCCR Drug; Deadline Looms

Soleno Therapeutics ($SLNO) faces securities fraud lawsuit over DCCR drug for Prader-Willi syndrome. Stock plunged following safety concerns, patient death, and weak Q3 results.
SLNOsecurities fraudclass action lawsuit